EUVIMEDAtrasti EUVIMED
Open access · CC BY 4.0

Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface

Mathilde Lethier iD, Karine Huard, Michael Hons iD, Adrien Favier iD, Bernhard Brutscher iD, Elisabetta Boeri Erba iD, Derek W Abbott iD, Stephen Cusack iD, Erika Pellegrini iD

Life Science Alliance · 2023-11 · 6 (11) · e202201784

DOI: 10.26508/lsa.202201784 ↗

At a glance

Journal article in Life Science Alliance, published online on 2023-09-06. Written by Mathilde Lethier and 8 co-authors. Institution: European Molecular Biology Laboratory, Grenoble, France. Major MEDLINE topics: Ubiquitin-Protein Ligases, Biological Assay. Cited 11 times so far (Crossref); 92 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, FRISBI, Ecoles Universitaires de Recherche.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

RIPK2 is an essential adaptor for NOD signalling and its kinase domain is a drug target for NOD-related diseases, such as inflammatory bowel disease. However, recent work indicates that the phosphorylation activity of RIPK2 is dispensable for signalling and that inhibitors of both RIPK2 activity and RIPK2 ubiquitination prevent the essential interaction between RIPK2 and the BIR2 domain of XIAP, the key RIPK2 ubiquitin E3 ligase. Moreover, XIAP BIR2 antagonists also block this interaction. To reveal the molecular mechanisms involved, we combined native mass spectrometry, NMR, and cryo-electron microscopy to determine the structure of the RIPK2 kinase BIR2 domain complex and validated the interface with in cellulo assays. The structure shows that BIR2 binds across the RIPK2 kinase antiparallel dimer and provides an explanation for both inhibitory mechanisms. It also highlights why phosphorylation of the kinase activation loop is dispensable for signalling while revealing the structural role of RIPK2–K209 residue in the RIPK2–XIAP BIR2 interaction. Our results clarify the features of the RIPK2 conformation essential for its role as a scaffold protein for ubiquitination.

Subjects

MeSH terms (MEDLINE)

Ubiquitin-Protein LigasesBiological AssayCryoelectron MicroscopyPhosphorylationUbiquitination

Substances

Ubiquitin-Protein Ligases

Authors and institutions

  • European Molecular Biology Laboratory, Grenoble, France.
  • University Grenoble Alpes, IBS, Grenoble, France.
  • CNRS, IBS, Grenoble, France.
  • CEA, IBS, Grenoble, France.
  • Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
  • European Molecular Biology Laboratory, Grenoble, France cusack@embl.fr.

ORCID profiles: Mathilde Lethier, Michael Hons, Adrien Favier, Bernhard Brutscher, Elisabetta Boeri Erba, Derek W Abbott, Stephen Cusack, Erika Pellegrini

Funding

  • NIGMS NIH HHS
  • FRISBI
  • Ecoles Universitaires de Recherche
  • CNRS
  • European Molecular Biology Laboratory

Cite

APA

Lethier, M., Huard, K., Hons, M., Favier, A., Brutscher, B., Boeri Erba, E., Abbott, D. W., Cusack, S., & Pellegrini, E. (2023). Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface. Life Science Alliance, 6(11), e202201784. https://doi.org/10.26508/lsa.202201784

Vancouver

Lethier M, Huard K, Hons M, Favier A, Brutscher B, Boeri Erba E, et al. Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface. Life Science Alliance. 2023;6(11):e202201784. doi:10.26508/lsa.202201784

BibTeX
@article{Lethier2023,
  author = {Lethier, Mathilde and Huard, Karine and Hons, Michael and Favier, Adrien and Brutscher, Bernhard and Boeri Erba, Elisabetta and Abbott, Derek W and Cusack, Stephen and Pellegrini, Erika},
  title = {Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface},
  journal = {Life Science Alliance},
  year = {2023},
  volume = {6},
  number = {11},
  pages = {e202201784},
  doi = {10.26508/lsa.202201784}
}
Start for free →